Abstract Objectives: Substance abuse is common in patients with psychiatric emergencies. To further understand the connection between substance abuse and…
Abstract Hintergrund: Seit dem 1. März 2017 ist medizinisches Cannabis (MC) bundesweit verschreibungsfähig. Zur Wirksamkeit von MC bei Fibromyalgiesyndrom (FMS)…
Abstract The lack of selective pharmacological tools has limited the full unraveling of G protein-coupled receptor 18 (GPR18) functions. The…
Abstract The Health Sciences Foundation has assembled a multi-disciplinary group around a series of questions about the impact of the…
Abstract Background: Cannabinoids have been suggested to alleviate frequently experienced symptoms of reduced mental well-being such as anxiety and depression.…
Abstract Cannabidiol (CBD) is a potential antidepressant agent. We examined the association between the antidepressant effects of CBD and alterations…
Abstract Depression and alcohol misuse, frequently comorbid, are associated with altered reward processing. However, no study has examined whether and…
Abstract The prevalence of depression is increasing worldwide, as is the number of people suffering from treatment-resistant depression; these patients…
Abstract Background: Frequent cannabis use is associated with a higher risk of developing cannabis use disorder and other adverse consequences.…
Abstract The period of adolescence is a stage during which individuals experience several physical and psychological changes which increase their…